Drug Research Topics

The On-Topic Netowork

Drug Research > Efficacy

The following information is about Efficacy.

Efficacy Defined

The ability of a drug to control or cure an illness.

This definition is in context to Drug Research. See more contextual defintions for Efficacy.


Navigation: [ 1 2 3 4 5 Next ]

Phase-III study shows Lucentis improves vision in branch retinal vein occlusion

Published July 3, 2009, 9:48 pm, PharmaBiz

Roche announced that the phase-III study BRAVO showed Lucentis (ranibizumab injection) improved vision, as measured by the primary endpoint of mean change from baseline in best-corrected visual acuity at six months, in patients with macular edema due to branch retinal vein occlusion.

Full Story


Epilepsy Victims Remain Deserted

Published July 3, 2009, 3:41 pm, Deepika

Epilepsy poses a burden to India having a huge population of 110 crores. There are 12 million people with epilepsy alive in India. This is similar to a population of Norway or Sweden.

Full Story


Monopoly Prices (Prices, Part 2)

Published July 3, 2009, 2:42 pm, Ludwig von Mises Institute

Competitive prices are the outcome of a complete adjustment of the sellers to the demand of the consumers.

Full Story


BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis

Published July 3, 2009, 6:59 am, redOrbit

TURKU, Finland, July 3 /PRNewswire/ -- BioCis Pharma Ltd., a privately held drug development company with its headquarters in Turku, Finland, announced positive results from its Phase IIa clinical trial of ProtoCure(TM) emulsion cream, the company's novel topical drug for dermatology.

Full Story


FDA Approves Multaq(R) For Patients With Atrial Fibrillation Or Atrial Flutter

Published July 3, 2009, 5:07 am, Medical News Today

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced that the U.S. Food and Drug Administration (FDA) has approved Multaq(R) (dronedarone) 400 mg Tablets. Patients with atrial fibrillation (AF) or atrial flutter (AFL) soon will have a new treatment option to help improve current management of their disease.

Full Story


My Pharmiweb.com

Published July 3, 2009, 4:49 am, PharmiWeb

Oslo, Norway, 3 July 2009 - Clavis Pharma ASA (OSE: CLAVIS) announces today that it has received clearance by the United States Food and Drug Administration (FDA) to include patients in the USA in its phase II clinical programme for Intravenous CP-4126.

Full Story


ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402

Published July 3, 2009, 3:59 am, redOrbit

LEUVEN, Belgium and LUND, Sweden, July 3 /PRNewswire-FirstCall/ -- ThromboGenics NV (Euronext Brussels: THR) and co-development partner BioInvent International (OMXS: BINV) announce that they have started recruitment of a second cohort of patients for their Phase II trial of TB-402.

Full Story


Cell Cycle Kinases as Therapeutic Targets for Cancer

Published July 3, 2009, 3:34 am, Newswise

A featured article in the July 2009 online issue of Nature Reviews/Drug Discovery that explores the prospects and progress of synthetic inhibitors to target cell cycle kinases in cancer forecasts that "novel compounds with increased potency, improved kinase specificity and favorable drug like properties will soon be available for clinical evaluation."

Full Story


Addex to Host R&D Day on July 16

Published July 3, 2009, 3:33 am, Marketwire

GENEVA, SWITZERLAND--(Marketwire - July 3, 2009) - Allosteric modulation company Addex Pharmaceuticals ( SWISS : ADXN ) invites investors, analysts, media and other interested parties to attend its annual R&D day on Thursday, July 16, 2009 in Geneva, Switzerland. Addex management will discuss advances made with its small molecule allosteric modulator drug discovery platform as well as the status ...

Full Story


Global Autoimmune Disease Therapeutics Market To Reach $50B By 2015, According To A New Report By Global Industry ...

Published July 3, 2009, 3:31 am, BioresearchOnline

Global market for Autoimmune Disease Therapeutics is projected to reach US$49.8B in 2015. Biologics emerged as the leading therapeutic option in the treatment of autoimmune diseases, owing to their superior efficacy compared to conventional small molecule drugs.

Full Story


Navigation: [ 1 2 3 4 5 Next ]

Are you looking for additional Drug Research > Efficacy news? Try our new "Efficacy News Focus" area.

Off-site Efficacy Links, User Submitted

The following links have been collected through user bookmark submission in the Efficacy category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Wed Jul 1

Tue Jun 30

  • http://researc h.acer.edu.au/ cgi/viewconten t.cgi?article= 1000&context=p rofessional_de v
  • La magia del punto G · ELPAÍS.com: De forma creciente las negociaciones multilaterales fracasan, los países ricos no honran sus compromisos financieros, los menos desarrollados incumplen sus promesas de reforma, los plazos no se respetan y los esfuerzos se estancan. ¿Qué hacer? Para comenzar es mejor no seguir intentando poner de acuerdo a 200 países con intereses cada vez más variados. Por lo tanto, una posibilidad es el minilateralism o: invitar a la mesa de negociaciones al menor número posible de países cuya participación es necesaria para lograr el máximo impacto sobre el problema. Éste es el número mágico. El punto G de las relaciones internacionale s.

Mon Jun 29

Fri Jun 26

Wed Jun 24

Sun Jun 21

Sat Jun 20

If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Efficacy. If you would like to find related tags we recommend Tag Patterns > Efficacy

Off-site Efficacy Research Links

If you still need additional information on Efficacy then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Drug Research

If you know the Drug Research Term Name use the links below to quickly jump to your desired focus.



Bookmark Us

The On Topic Network

This website is part of The On Topic Network.

Thank You

Drug-Research.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.

License

Creative Commons License This work is licensed under Creative Commons.


Your Ad Here
Your Ad Here

Powered by Odin Assemble 2.5a